LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator

(2021) Lila Allou et al.   NATURE

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

(2021) Lan Mu et al.   Journal of Translational Medicine

C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target

(2020) PITHI CHANVORACHOTE et al.   ANTICANCER RESEARCH

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling

(2020) Jinchang Pan et al.   Molecular Cancer

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis

(2020) Yanchao Xin et al.   OncoTargets and Therapy

MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway

(2020) Xin Luo et al.   BIOMEDICINE & PHARMACOTHERAPY

MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2

(2020) Lifeng Huang et al.   PHARMACOLOGICAL RESEARCH

A long intergenic non-coding RNA LINC01426 promotes cancer progression via AZGP1 and predicts poor prognosis in patients with lung adenocarcinoma

(2020) Baorui Tian et al.   Molecular Therapy-Methods & Clinical Development

Relevance Function of Linc-ROR in the Pathogenesis of Cancer

(2020) Wenjian Chen et al.   Frontiers in Cell and Developmental Biology

Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non–small Cell Lung Cancer

(2020) Yusuke Inoue et al.   JAMA Network Open

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

(2019) Tony S K Mok et al.   LANCET

Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis

(2019) Marina R. Hadjicharalambous et al.   Scientific Reports

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

(2019) E J Aguilar et al.   ANNALS OF ONCOLOGY

MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR)

(2018) Amr Al-Haidari et al.   CANCER LETTERS

Functional Classification and Experimental Dissection of Long Noncoding RNAs

(2018) Florian Kopp et al.   CELL

Cav-1 promote lung cancer cell proliferation and invasion through lncRNA HOTAIR

(2018) Wei Liu et al.   GENE

Regulation and Function of the PD-L1 Checkpoint

(2018) Chong Sun et al.   IMMUNITY

Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth

(2018) Shengping Zhai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Long noncoding RNA s as regulators of cancer immunity

(2018) Nerina Denaro et al.   Molecular Oncology

Lung cancer

(2017) Richard Barnett   LANCET

Lung cancer: current therapies and new targeted treatments

(2017) Fred R Hirsch et al.   LANCET

Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway

(2017) Yun Cui et al.   Oncotarget

A three-lncRNA expression signature associated with the prognosis of gastric cancer patients

(2017) Peng Song et al.   Cancer Medicine

Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells

(2016) Haishan Huang et al.   Autophagy

Progression and metastasis of lung cancer

(2016) Helmut H. Popper   CANCER AND METASTASIS REVIEWS

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

PD-L1 Expression in Lung Cancer

(2016) Hui Yu et al.   Journal of Thoracic Oncology

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

MYC regulates the antitumor immune response through CD47 and PD-L1

(2016) S. C. Casey et al.   SCIENCE

Classification and Pathology of Lung Cancer

(2016) Min Zheng   Surgical Oncology Clinics of North America

Linking Long Noncoding RNA Localization and Function

(2016) Ling-Ling Chen   TRENDS IN BIOCHEMICAL SCIENCES

Lung cancer and metastasis: new opportunities and challenges

(2015) Xiangdong Wang et al.   CANCER AND METASTASIS REVIEWS

Downregulation of microRNA-33a promotes cyclin-dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation

(2015) YUDONG WANG et al.   Molecular Medicine Reports

DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts

(2015) Maria D. Paraskevopoulou et al.   NUCLEIC ACIDS RESEARCH

Long Noncoding RNAs: Cellular Address Codes in Development and Disease

(2013) Pedro J. Batista et al.   CELL

Long non-coding RNAs: new players in cell differentiation and development

(2013) Alessandro Fatica et al.   NATURE REVIEWS GENETICS

Genome Regulation by Long Noncoding RNAs

(2012) John L. Rinn et al.   Annual Review of Biochemistry